Reduce time, save money
M2S supports your device development, from pre-market data, to clinical trials services and imaging core lab, to registry-based post-market, RCT and IDE studies. We combine powerful data with cost effective and experienced project management to help lower costs, reduce administrative tasks and shorten development lead times.
Everyone – from the device companies, to the FDA, to insurers – is asking the same question: how do we reduce the time and cost to bring safe and effective therapies to market?
BETTER ON EVERY LEVEL
M2S has the answer. We offer:
- Better retrospective and prospective registry data and imaging in pre-market stages to help create a more effective process for R&D and marketing.
- Better data and imaging combined with cost-effective management in clinical trials to help streamline process manage trial costs
- Better prospective, registry-based data in post-approval to accelerate the site and patient recruitment, while minimizing site administration
At every stage, access to better data sooner can make the difference.
FUN FACT QUESTION: Name the first five centers to join the VQI?
ANSWER:
Boston Medical Center, Elliott Hospital, Tufts Medical Center, UMass Memorial Hospital and Fletcher Allen Healthcare.
